FDA clears three labeling supplements for palonosetron, letrozole, carbamazepineSep 17Weekly roundup, 3 itemscarbamazepineletrozole
Lilly posts results for five completed Phase 1 studies, opens three new early trialsJul 17Weekly roundup, 8 itemsEli Lillyeloralintide
Novartis posts pelacarsen Phase 3 apheresis results, updates three drug labelsJul 17Weekly roundup, 8 itemscarbamazepineimatinib
Sign inSign in